Behandling med Neulasta alene forhindrer ikke thrombocytopeni og anæmi forårsaget af at fuld dosis myelosuppressiv kemoterapi opretholdes efter foreskrevet skema.
Treatment with Neulasta alone does not preclude thrombocytopenia and anaemia because full dose myelosuppressive chemotherapy is maintained on the prescribed schedule.